The Cell Therapy Commercialization Summit is next week!

The Cell Therapy Commercialization Summit is only one week away!

Are you confident that your current clinical development plan will take your product from approval to successful commercialization?

Are you looking for a roadmap to ensure financial solvency throughout clinical development?

Do you want to maximize your valuable time away from the office at a minimum of expense?

In three days you will learn strategies to:
1. Manage Costs to Control the Spending Burn and Remain Self-Sustaining
2. Choose the Right Design Parameters for Trial Efficiency and Sustainability
3. Minimize Waste, Maximize Efficiencies, and Speed Up Timelines During the Clinical Trial Transition
4. Optimize Cell Product Quality of Ancillary Materials
5. Incorporate the Concepts of Pharmaceutical Quality Systems into Cell Therapy Product Development
6. Leverage Manufacturing Process Technologies to Maximize Capacity and Minimize Cost-of-Goods

For more information on the event, download the brochure.  We hope to see you next week at the Clinical Business Expo!

Share this article with your social network, just click below to share now!

Share |

Is the cell therapy industry poised for a breakthrough?

Dr. Arnold Caplan, Director, Skeletal Research at Case Western Reserve University, recently sat down with the Cell Therapy Commercialization team to look at the current state and future of the cell therapy industry.

He answered questions including:
- What are the current hot topics in cell therapy?
- Where is the cell therapy industry in terms of advanced products?
- Is the cell therapy industry poised for a breakthrough?
- Is big Pharma taking more steps to partner with smaller firms/non-profits/governments working on cell therapy?

To hear Dr. Caplan's responses to these questions, download the Cell Therapy Commercialization Summit podcast here.

Dr Caplan will be presenting Industry Overview – The Current Status of the Cell Therapy Business on Tuesday, September 20 at the Cell Therapy Commercialization Summit.  To find out more about his presentation, and the rest of the program featuring Anthony Atala, Institute for Regenerative Medicine, Brock Reeve, Harvard Stem Cell Institute, Ian Harris, Stem Cell Org. of Johnson and Johnson, download the brochure here.

Share this article with your social network, just click below to share now!

Share |

South Korea could be the first country to approve stem cell therapy

The Korea Food and Drug Administration (KFDA) could be the first in the world to approve stem cell therapy as a medicine in the world.  According to the Yonhap News Agency, the therapy would treat acute myocardial infarction.  The stem cells are harvested from the person's body then treated and injected back into the heart. It has passed the safety and validity tests needed for approval.

This September, The Cell Therapy Commercialization Summit will be join by AON Insurance, Argenta Advisors and others to identify how companies can ensure reimbursement for cell therapy treatments long before they are approved by the US FDA. For more about the Cell Therapy Commercialization Summit, download the brochure.

What could approval of a stem cell therapy in South Korea mean for other pending approvals across the world?

Share this article with your social network, just click below to share now!

Share |

Cell Therapy Commercialization Summit Brochure available for download

The Cell Therapy Commercialization Summit is the only multi-stakeholder event that delivers a comprehensive tool kit for taking your cell therapy product from preclinical all the way to commercialization – in only three days.

At the Summit, join over 15 sessions are devoted to the complete clinical development life-cycle, including:

• → Testing: Use Stem Cell Derived Models for Development Toxicity to Ensure Product Progress
• → Partnering: Manage Big Pharma Alliances to Ensure Effective Cell Therapy Partnerships
• → Financing: Manage Costs to Control the Spending Burn and Remain Self-Sustaining
• → Designing: Choose the Right Design Parameters for Trial Efficiency and Sustainability
• → Ensuring Quality: Incorporating the Concepts of Pharmaceutical Quality Systems into Cell Therapy Product Development
• → Manufacturing: Run a Bioprocessing Mechanism that Will Give you a Viable Cost to Goods Model
• → Storing: Maintain Quality and Maximize Efficiencies in Post-Production Logistics
• → Delivering: Overcome Cold Chain Inefficiencies to Deliver a Fully Potent, Commercially Viable Product

Download the brochure today.

The Cell Therapy Commercialization Summit is a part of the Clinical Business Expo, the host location and home to 6 exclusive and successful conferences all related to clinical business to deliver the latest technical, operational and scientific approaches for clinical development continuum.  Find out more about CBE, taking place September 19-21, 2011 in Boston, MA here.

Share this article with your social network, just click below to share now!

Share |